Early research (Phase 1)Study completedNCT01722526
What this trial is testing
Tolerability and Safety Study of Recombinant Human Acid Sphingomyelinase in Acid Sphingomyelinase Deficiency Patients
Who this might be right for
Human Acid Sphingomyelinase Deficiency
Genzyme, a Sanofi Company 5